Healthpeak Properties (HCP) (PEAK) Prices 15M Share Common Offering at $35/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day losing streak as stocks reclaim some shine
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
UPDATE: Healthpeak Properties Inc. (PEAK) Announces Sara Grootwassink Lewis to Board
November 5, 2019 5:20 PM EST(Updated - November 5, 2019 5:20 PM EST)
Healthpeak Properties, Inc. (NYSE: PEAK) today announced the appointment of Sara Grootwassink Lewis as an independent director to its Board of Directors, effective immediately. The appointment of Ms. Lewis expands the Board to eight directors, with an average director tenure of approximately five years.
Brian Cartwright, Healthpeak's Chairman of the Board, stated, "The addition of Sara... More
Healthpeak Properties (HCP) Announces Public Offering of Common Stock on Forward Basis
November 4, 2019 4:56 PM ESTHealthpeak Properties, Inc. (NYSE: HCP) ("Healthpeak") announced today that it has commenced a public offering of an aggregate of 15,000,000 shares of its common stock in connection with the forward sale agreement described below. The underwriters are expected to be granted a 30-day option to purchase up to an additional 2,250,000 shares of Healthpeak's common stock.
BofA Securities and Morgan Stanley are acting as joint... More
HCP (HCP) PT Raised to $40 at RBC Capital
November 4, 2019 6:46 AM ESTRBC Capital analyst Michael Carroll raised the price target on HCP (NYSE: HCP) to $40.00 (from $36.00) while maintaining a Outperform rating.... More
